Dr. Krause is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dept of Biochemistry
Otago University, New Zealand
Houston, TX 77055
Summary
- Trained in infectious diseases in the US. Now working in New Zealand at Otago University on drug discovery and pathogenesis research.
Education & Training
Baylor College of MedicineClass of 1980
Certifications & Licensure
TX State Medical License 1980 - 2025
Publications & Presentations
PubMed
- 19 citationsThe crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation.Chetlen R. Crossnoe, Juris P. Germanas, Pierre LeMagueres, Gabriela Mustata, Kurt L. Krause
Journal of Molecular Biology. 2002-04-26 - 21 citationsReactivity of Reduced [2Fe-2S] Ferredoxins Parallels Host Susceptibility to NitroimidazolesMomcilo Vidakovic, Chetlen R. Crossnoe, Christopher Neidre, Kyonghee Kim, Kurt L. Krause
Antimicrobial Agents and Chemotherapy. 2003-01-01 - 144 citationsEmergence of Macrolide Resistance during Treatment of Pneumococcal PneumoniaDaniel M. Musher, Mark E. Dowell, Virginia D. Shortridge, Robert K. Flamm, James H. Jorgensen
The New England Journal of Medicine. 2002-02-21
Press Mentions
Live: Experts Warn 'Race Is On' as New Covid Drug Set for NZDecember 7th, 2021- Govt Urged to Buy 'Game Changer' Covid-19 Drug TreatmentSeptember 15th, 2021
- Coronavirus: Hydroxychloroquine Researchers Angry, Embarrassed by Dodgy StudiesJune 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
